Patents by Inventor Karl-Heinz Sellinger

Karl-Heinz Sellinger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7659373
    Abstract: The invention concerns new EPO compositions with high specific activity which are characterized by a high proportion of N-acetyl-lactosamine units or/and tetraantennary branches in the carbohydrate structure. In addition the invention concerns a process for producing such EPO products.
    Type: Grant
    Filed: August 9, 2005
    Date of Patent: February 9, 2010
    Assignee: Roche Diagnostics GmbH
    Inventors: Josef Burg, Karl-Heinz Sellinger, Anton Haselbeck, Hans Koll
  • Publication number: 20050288220
    Abstract: The invention concerns new EPO compositions with high specific activity which are characterized by a high proportion of N-acetyl-lactosamine units or/and tetraantennary branches in the carbohydrate structure. In addition the invention concerns a process for producing such EPO products.
    Type: Application
    Filed: August 9, 2005
    Publication date: December 29, 2005
    Inventors: Josef Burg, Karl-Heinz Sellinger, Anton Haselbeck, Hans Koll
  • Patent number: 6471500
    Abstract: A process for producing erythropoietin which is free of foreign animal proteins except for the proteins of the host cell, wherein DNA coding for EPO is expressed in a eukaryotic host cell and the host cell is cultured in a medium free of natural mammalian proteins. The erythropoietin is chromatographically purified using dye affinity chromatography, chromatography on hydroxyapatite, reversed phase chromatography, and anion exchange chromatography. The resulting preparation contains less than 100 ppm of proteins derived from the host cell, and less than 10 pg of host cell DNA per 83 &mgr;g erythropoietin.
    Type: Grant
    Filed: February 7, 2002
    Date of Patent: October 29, 2002
    Inventors: Josef Burg, Walter Schneider, Alexander Wrba, Werner Fürst, Karl-Heinz Sellinger
  • Publication number: 20020146771
    Abstract: A process for producing erythropoietin which is free of foreign animal proteins except for the proteins of the host cell, wherein DNA coding for EPO is expressed in a eukaryotic host cell and the host cell is cultured in a medium free of natural mammalian proteins. The erythropoietin is chromatographically purified using dye affinity chromatography, chromatography on hydroxyapatite, reversed phase chromatography, and anion exchange chromatography. The resulting preparation contains less than 100 ppm of proteins derived from the host cell, and less than 10 pg of host cell DNA per 83 &mgr;g erythropoietin.
    Type: Application
    Filed: February 7, 2002
    Publication date: October 10, 2002
    Applicant: Roche Diagnostics GmbH
    Inventors: Josef Burg, Walter Schneider, Alexander Wrba, Werner Furst, Karl-Heinz Sellinger
  • Patent number: 6399333
    Abstract: A process for producing erythropoietin which is free of foreign animal proteins except for the proteins of the host cell, wherein DNA coding for EPO is expressed in a eukaryotic host cell and the host cell is cultured in a medium free of natural mammalian proteins. The erythropoietin is chromatographically purified using dye affinity chromatography, chromatography on hydroxyapatite, reversed phase chromatography, and anion exchange chromatography. The resulting preparation contains less than 100 ppm of proteins derived from the host cell, and less than 10 pg of host cell DNA per 83 &mgr;g erythropoietin.
    Type: Grant
    Filed: February 13, 1998
    Date of Patent: June 4, 2002
    Assignee: Roche Diagnostics GmbH
    Inventors: Josef Burg, Walter Schneider, Alexander Wrba, Werner Fürst, Karl-Heinz Sellinger